Global Recombinant Non-Glycosylated Proteins Biosimilars Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3495841
- 89 Pages
- February 2020
- Healthcare
The global Recombinant Non-Glycosylated Proteins Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Non-Glycosylated Proteins Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Insulin
rHGH
Interferon
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy’s Laboratories
Stada Arzneimittel AG
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Recombinant Non-Glycosylated Proteins Biosimilars Industry
Figure Recombinant Non-Glycosylated Proteins Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Non-Glycosylated Proteins Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Non-Glycosylated Proteins Biosimilars
1.2.2 Downstream
Table Application Segment of Recombinant Non-Glycosylated Proteins Biosimilars
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Recombinant Non-Glycosylated Proteins Biosimilars Market by Type
3.1 By Type
3.1.1 Insulin
Table Major Company List of Insulin
3.1.2 rHGH
Table Major Company List of rHGH
3.1.3 Interferon
Table Major Company List of Interferon
3.2 Market Size
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Type, in USD Million
Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2015-2019, by Type, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Type, in Volume
Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Sandoz (Company Profile, Sales Data etc.)
4.1.1 Sandoz Profile
Table Sandoz Overview List
4.1.2 Sandoz Products & Services
4.1.3 Sandoz Business Operation Conditions
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer (Company Profile, Sales Data etc.)
4.2.1 Pfizer Profile
Table Pfizer Overview List
4.2.2 Pfizer Products & Services
4.2.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva Pahrmaceutical (Company Profile, Sales Data etc.)
4.3.1 Teva Pahrmaceutical Profile
Table Teva Pahrmaceutical Overview List
4.3.2 Teva Pahrmaceutical Products & Services
4.3.3 Teva Pahrmaceutical Business Operation Conditions
Table Business Operation of Teva Pahrmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Celltrion (Company Profile, Sales Data etc.)
4.4.1 Celltrion Profile
Table Celltrion Overview List
4.4.2 Celltrion Products & Services
4.4.3 Celltrion Business Operation Conditions
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Biocon (Company Profile, Sales Data etc.)
4.5.1 Biocon Profile
Table Biocon Overview List
4.5.2 Biocon Products & Services
4.5.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Amgen (Company Profile, Sales Data etc.)
4.6.1 Amgen Profile
Table Amgen Overview List
4.6.2 Amgen Products & Services
4.6.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Samsung Biologics (Company Profile, Sales Data etc.)
4.7.1 Samsung Biologics Profile
Table Samsung Biologics Overview List
4.7.2 Samsung Biologics Products & Services
4.7.3 Samsung Biologics Business Operation Conditions
Table Business Operation of Samsung Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Mylan (Company Profile, Sales Data etc.)
4.8.1 Mylan Profile
Table Mylan Overview List
4.8.2 Mylan Products & Services
4.8.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
4.9.1 Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Overview List
4.9.2 Dr. Reddy’s Laboratories Products & Services
4.9.3 Dr. Reddy’s Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Stada Arzneimittel AG (Company Profile, Sales Data etc.)
4.10.1 Stada Arzneimittel AG Profile
Table Stada Arzneimittel AG Overview List
4.10.2 Stada Arzneimittel AG Products & Services
4.10.3 Stada Arzneimittel AG Business Operation Conditions
Table Business Operation of Stada Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue Share in 2019, by Company, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2019
Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Market Concentration, in 2019
Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars MMarket Concentration, in 2019
Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2019
Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Oncology, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Oncology, 2015-2019, in Volume
6.1.2 Demand in Chronic Diseases
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Chronic Diseases, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Chronic Diseases, 2015-2019, in Volume
6.1.3 Demand in Autoimmune Diseases
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Autoimmune Diseases, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Autoimmune Diseases, 2015-2019, in Volume
6.1.4 Demand in Blood Disorders
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Blood Disorders, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Blood Disorders, 2015-2019, in Volume
6.1.5 Demand in Growth Hormone Deficiency
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Growth Hormone Deficiency, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Growth Hormone Deficiency, 2015-2019, in Volume
6.1.6 Demand in Infectious Diseases
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Infectious Diseases, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Infectious Diseases, 2015-2019, in Volume
6.1.7 Demand in Other Diseases
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Other Diseases, 2015-2019, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Other Diseases, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2020-2025, by Application, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2020-2025, by Application, in USD Million
Figure Recombinant Non-Glycosylated Proteins Biosimilars Market Share in 2025, by Application, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2020-2025, by Application, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2015-2019, by Region, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Region, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Region, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in USD Million
Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in USD Million
Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in USD Million
Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Recombinant Non-Glycosylated Proteins Biosimilars
Table Application Segment of Recombinant Non-Glycosylated Proteins Biosimilars
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2025, by Application, in USD Million
Table Major Company List of rHGH
Table Major Company List of Interferon
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Type, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Type, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Type, in Volume
Table Sandoz Overview List
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pahrmaceutical Overview List
Table Business Operation of Teva Pahrmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celltrion Overview List
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Samsung Biologics Overview List
Table Business Operation of Samsung Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Overview List
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Stada Arzneimittel AG Overview List
Table Business Operation of Stada Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2020-2025, by Application, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2020-2025, by Application, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Share in 2025, by Application, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2015-2019, by Region, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2015-2019, by Region, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Region, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2015-2019, by Region, in Volume
Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2015-2019, by Region, in Volume
Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2015-2019, by Country, in Volume
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
